Veille Scientifique

La veille scientifique est un nouveau service proposé par la SNFGE. Elle se veut un recensement rapide et assez exhaustif des articles publiés dans les revues majeures (New England Journal of Medicine, Lancet, JAMA, Gastroenterology, Gut, Lancet Oncology, Journal of Clinical Oncology, Hepatology, Journal of Hepatology, Endoscopy, Gastrointestinal Endoscopy...).
 

Patrice PIENKOWSKI
 Coordinateur

Six groupes animés par un responsable se chargent de ce travail tous les mois :

Cancers Endoscopie Foie/
VB
Gastro/
Procto/

Nutrition
MICI Pancréas
R. FAROUX E. CORON C. SILVAIN P. JOUET S. NAHON V. REBOURS
T. APARICIO
B. DENIS
S. MANFREDI
Y. TOUCHEFEU
D. TOUGERON

C. CELLIER
E. CHABRUN
F. ROSTAIN
JM. ROUILLON

B. HANSLIK
JL. PAYEN
JM. PERON
D. VALLA

H. DAMON
P. DUCROTTE
F. CORDET
V. COSTIL
P. COULOM
V. de PARADES
F. ZERBIB

V. ABITBOL
P. FAURE
P. MARTEAU
B. PARIENTE
P. SEKSIK
M. CAMUS
P. DELASALLE
L. de MESTIER


Nous espérons de ce nouvel outil qu’il vous aide à accéder rapidement et sélectivement aux données nouvelles de notre discipline selon vos sujets d’intérêt, qu’ils soient larges ou très spécifiques.

Revue Titre Date Coup de coeur Thématique
The Lancet Oncology Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2-3 trial. mar. 17 4 ♥ Carcinome hépatocellulaire (CHC)
The Lancet Oncology Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial. mar. 17 4 ♥ Cancer colorectal (CCR)
The Lancet Oncology Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial. mar. 17 4 ♥ Cancers autres
Gut Adenoma detection with Endocuff colonoscopy versus conventional colonoscopy: a multicentre randomised controlled trial mar. 17 3 ♥ Endoscopie - Imagerie
The Lancet Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. mar. 17 5 ♥ Pancréas/voies bilaires
Gut Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing non-operative management: a mid-term follow-up analysis. mar. 17 5 ♥ Pancréas/voies bilaires
Gut Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitis mar. 17 3 ♥ Pancréas/voies bilaires
Gastroenterology A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients With New-Onset Diabetes. mar. 17 1 ♥ Pancréas/voies bilaires
Gastroenterology Budesonide Oral Suspension Improves Symptomatic, Endoscopic, and Histologic Parameters Compared With Placebo in Patients With Eosinophilic Esophagitis. mar. 17 4 ♥ Endoscopie/Imagerie
The American Journal of Gastroenterology Effectiveness of Guideline-Recommended Cholecystectomy to Prevent Recurrent Pancreatitis. mar. 17 2 ♥ Pancréas/voies bilaires
Annals of oncology Investigating the poor outcomes of BRAF-mutant advanced colorectal cancer: Analysis from 2530 patients in randomised clinical trials. mar. 17 2 ♥ Cancer colorectal (CCR)
British journal of Cancer Body weight trajectories and risk of oesophageal and gastric cardia adenocarcinomas: a pooled analysis of NIH-AARP and PLCO Studies mar. 17 2 ♥ Cancers autres (hors CCR et CHC)
Digestive and Liver Disease Additional mailing phase for FIT after a medical offer phase: The best way to improve compliance with colorectal cancer screening in France mar. 17 3 ♥ Cancer colorectal (CCR)
Gastroenterology Real-Time Monitoring of Results During First Year of Dutch Colorectal Cancer Screening Program and Optimization by Altering Fecal Immunochemical Test Cut-Off Levels. mar. 17 3 ♥ Cancer colorectal (CCR)
Hepatology Antiviral treatment and liver-related complications in hepatitis delta. fév. 17 3 ♥ Foie
Hepatology Metabolic and hepatic effects of bloodletting in dysmetabolic iron overload syndrome: A randomized controlled study in 274 patients. fév. 17 5 ♥ Foie
Hepatology Rifaximin has no effect on hemodynamics in decompensated cirrhosis: A randomized, double-blind, placebo-controlled trial. fév. 17 3 ♥ Foie
Hepatology Hyperoxidized albumin modulates neutrophils to induce oxidative stress and inflammation in severe alcoholic hepatitis. fév. 17 4 ♥ Foie
Hepatology Short-duration treatment with elbasvir/grazoprevir and sofosbuvir for hepatitis C: A randomized trial. fév. 17 3 ♥ Foie
Hepatology Low-grade endotoxemia and platelet activation in cirrhosis. fév. 17 4 ♥ Foie
Journal of Hepatology HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe. fév. 17 4 ♥ Foie
Journal of Hepatology Extensive testing or focused testing of patients with elevated liver enzymes. fév. 17 4 ♥ Foie
Hepatology Five-year histological and serological follow-up of operationally tolerant pediatric liver transplant recipients enrolled in WISP-R. fév. 17 4 ♥ Foie
Journal of Hepatology Are targeted treatment recommendations in chronic hepatitis C tailored to diagnostic methods of fibrosis? fév. 17 2 ♥ Foie
Journal of Hepatology Reduction of covalently closed circular DNA with long-term nucleos(t)ide analogue treatment in chronic hepatitis B. fév. 17 3 ♥ Foie

Pages